Primary Record
SORIVUDINE
- In stock
- 3,330 g
- Purity
- 98.9 %
- CAS
- 77181-69-2
Compound Identifiers & Properties
- CAS
- 77181-69-2
- PubChem CID
- 5282192
- SMILES
- C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O)/C=C/Br
- Canonical SMILES
- O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C/Br
Names & Synonyms
- SORIVUDINE
- Bravavir
- Usevir
- Brovavir
- Sorivudina
- BV-araU
- Sorivudinum
- Bromovinyluridine
- 5-Bromovinyl-araU
- BV-Ara-U
- BVaraU
- BVAU
- Bromovinyl araU
- 77181-69-2
- YN-72
- Bravavir (TN)
- Usevir (TN)
- Sorivudinum [INN-Latin]
- BV ara-U
- Sorivudina [INN-Spanish]
- C7VOZ162LV
- SQ-32756
- ARYS-01
- C11H13BrN2O6
- SORIVUDINE [MI]
- UNII-C7VOZ162LV
- AC1NQZN1
- SORIVUDINE [INN]
- SORIVUDINE [JAN]
- RefChem:888366
- CCRIS 5285
- SORIVUDINE [USAN]
- (E)-5-(2-Bromovinyl)uridine
- CHEMBL70046
- D03TGJ
- SORIVUDINE [MART.]
- SORIVUDINE [WHO-DD]
- SCHEMBL82640
- DRU-0136
- Sorivudine (JAN/USAN/INN)
- orb1307733
- Sorivudine [USAN:BAN:INN:JAN]
- Sorivudine [USAN:INN:BAN:JAN]
- DTXCID7031616
- DTXSID6057827
- CHEBI:32152
- SQ 32,756
- MFCD00866949
- SO-32756
- C11-H13-Br-N2-O6
- ZINC3653374
- BDBM50206491
- EX-A10744
- JA-001
- AKOS025149268
- CID5282192
- DB11998
- (E)-5-(2-Bromovinyl)-1-beta-D-arabinofuranosyluracil
- 1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil
- 1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil
- AS-73022
- DA-67698
- SQ 32756
- HY-123032
- J242.999C
- LS-135099
- SO 32,756
- 5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil
- CS-0080932
- NS00069168
- 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil
- D01734
- D93116
- (+)-1-beta-D-Arabinofuranosyl-5-((E)-2-bromovinyl)uracil
- (E)-1-beta-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione
- 1-benzyl-4-cyanomethyl-piperidine-4-carbonitrile
- F843954
- Q905418
- 1-.beta.-D-arabinofuranosyl-5-(2-bromovinyl)uracil
- 1-beta-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
- A1037986
- 1-beta-D-Arabinofuranosyl-5-[(E)-2-bromoethenyl]uracil
- 5-((E)-2-bromovinyl)-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
- 1-(beta-D-Arabinofuranosyl)-5-[(E)-2-bromoethenyl]uracil
- (+)-1-Beta-D-arabinofuranosyl-5-((E)-2-bromovi-ny1) uracil
- 5-[(1E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
- 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)-, (E)-
- 2,4(1H,3H)-pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)
- 5-[(E)-2-bromovinyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione
- (E)-1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione,
- 1-|A-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
- 1-beta-D-Arabinofuranosyl-5-[(E)-2-bromovinyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 2,4(1H,3H)-Pyrimidinedione, 1-.beta.-D-arabinofuranosyl-5-[(1E)-2-bromoethenyl]-
- 5-((E)-2-Bromo-vinyl)-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-4-hydroxy-1H-pyrimidin-2-one
- 5-((E)-2-bromoethenyl)-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 80434-16-8